QuantiGene cancer and disease research assay kits
QuantiGene cancer and disease research assay kits enable direct quantification of miRNA, mRNA or DNA targets directly from any sample. They are based on the branched DNA (bDNA) signal amplification technology used in Siemens’ FDA-approved Versant assays for HIV and Hepatitis C viral load testing.
Each kit contains everything needed to detect and quantify or view genes or transcripts of interest. Simply provide the accession number or sequence information for those genes or transcripts and Affymetrix will generate the necessary probe sets to be used in each assay kit.
The assays deliver unparalleled flexibility in three formats: ViewRNA for applications involving expression heterogeneity, infectious diseases, stem cells and differentiation, miRNA analysis, cancer tissue analysis; 2.0 to validate microarray results, quantify siRNA knockdowns, quantify DNA copy number, quantify miRNAs, detect translocations and fusion genes; and Plex for gene signatures, pathway analysis, DNA copy number analysis and biomarker detection in clinical samples.
Phone: 1800 678 242
Lonza 4D-Nucleofector LV Unit PRO electroporation unit
Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...
Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)
The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...
Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms
The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...